Casper Breum

Biography

Casper joined Lundbeckfonden Ventures in 2009 and is currently a board member of Atox Bio, Biom’Up, Dysis Medical, Sanifit and Spero Therapeutics. In his prior work life, Casper gained broad international experience from almost 20 years in the pharma and biotech industry covering areas such as chemistry, project management, outsourcing, international quality audits, business development, alliance management, and general management. Casper was previously CEO of ilochip A/S, a venture backed company focused on development of diagnostic biochips. Before this he held different positions at H. Lundbeck A/S most recently in corporate business development and strategy. Prior to his work at H. Lundbeck, Casper worked for Novo Nordisk A/S and Niels Clauson-Kaas A/S. While working at H. Lundbeck A/S he was member of the board of directors of Lundbeckfonden and Lundbeckfond Invest A/S as an employee representative. Casper has an MSc in organic chemistry and an MBA in innovation and new business creation, both from the Technical University of Denmark.

Research Interest

Organic Chemistry